Drug Type Chemical drugs |
Synonyms- |
Target |
Action inhibitors |
Mechanism DUB inhibitors(zinc finger containing ubiquitin peptidase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Preclinical | France | 10 Oct 2011 | |
| Cardiovascular Diseases | Preclinical | France | 10 Oct 2011 | |
| Central Nervous System Diseases | Preclinical | France | 10 Oct 2011 | |
| Central Nervous System Diseases | Preclinical | France | 10 Oct 2011 | |
| Diabetes Mellitus | Preclinical | France | 10 Oct 2011 | |
| Diabetes Mellitus | Preclinical | France | 10 Oct 2011 | |
| Eye Diseases | Preclinical | France | 10 Oct 2011 | |
| Eye Diseases | Preclinical | France | 10 Oct 2011 | |
| Neurotic Disorders | Preclinical | France | 10 Oct 2011 | |
| Neurotic Disorders | Preclinical | France | 10 Oct 2011 |





